[HTML][HTML] Identification of a novel quinoxaline-isoselenourea targeting the STAT3 pathway as a potential melanoma therapeutic

V Alcolea, DN Karelia, MK Pandey, D Plano… - International journal of …, 2019 - mdpi.com
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …

[PDF][PDF] Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic

V Alcolea, DN Karelia, MK Pandey, D Plano, P Singh… - Int. J. Mol. Sci, 2019 - academia.edu
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …

Identification of a novel quinoxaline-isoselenourea targeting the STAT3 pathway as a potential melanoma therapeutic

V Alcolea, DN Karelia, MK Pandey, D Plano… - International journal of …, 2019 - pure.psu.edu
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …

[HTML][HTML] Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic

V Alcolea, DN Karelia, MK Pandey… - … Journal of Molecular …, 2019 - ncbi.nlm.nih.gov
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …

Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic

V Alcolea, DN Karelia, MK Pandey, D Plano, P Singh… - 2019 - agris.fao.org
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …

Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic.

V Alcolea, DN Karelia, MK Pandey, D Plano… - … Journal of Molecular …, 2019 - europepmc.org
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …

Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic

V Alcolea, DN Karelia, MK Pandey, D Plano… - International Journal of …, 2019 - hero.epa.gov
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …

Identification of a novel quinoxaline-isoselenourea targeting the STAT3 pathway as a potential melanoma therapeutic

V Alcolea, DN Karelia, MK Pandey… - International …, 2019 - researchwithrowan.com
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …

[PDF][PDF] Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic

V Alcolea, DN Karelia, MK Pandey, D Plano… - Int. J. Mol …, 2019 - pdfs.semanticscholar.org
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …

Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic

V Alcolea, DN Karelia, MK Pandey… - International …, 2019 - pubmed.ncbi.nlm.nih.gov
The prognosis for patients with metastatic melanoma remains very poor. Constitutive signal
transducer and activator of transcription 3 (STAT3) activation has been correlated to …